NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA).
SIGN THE PETITION

Dr. Siddharth Nath

Staff Writer

Montréal, Québec, Canada

Dr. Siddharth Nath is a resident physician in ophthalmology at McGill University in Montréal, Québec, Canada. Previously, he completed the MD/PhD Program at McMaster University and also holds an Honours Bachelor of Science in Biochemistry from McMaster. His PhD research, conducted in the laboratory of Dr. Ray Truant, focused on the role of cellular stress in neurodegenerative disorders like Huntington’s disease and SCA7. He maintains an active interest in the ocular sequelae of genetic neurodegenerative disorders.